Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for G Medical Innovations Holdings's EV-to-OCF or its related term are showing as below:
GMVDF's EV-to-OCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.865 * Ranked among companies with meaningful EV-to-OCF only.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
G Medical Innovations Holdings (OTCPK:GMVDF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
G Medical Innovations Holdings's PE Ratio (TTM) for today is calculated as:
G Medical Innovations Holdings's share price for today is $0.0001.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-51.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
G Medical Innovations Holdings EV-to-OCF Related Terms
G Medical Innovations Holdings EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, G Medical Innovations Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
G Medical Innovations Holdings EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where G Medical Innovations Holdings's EV-to-OCF falls into.
G Medical Innovations Holdings's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2022 was $-18.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
G Medical Innovations Holdings (GMVDF) has a EV-to-OCF of 0.00 as of Sep. 17, 2026.
Is G Medical Innovations Holdings' EV-to-OCF too high?
G Medical Innovations Holdings' current EV-to-OCF is 0.00. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' EV-to-OCF compare to WHSI and ISRG?
G Medical Innovations Holdings' EV-to-OCF of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-OCF is 7.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.87, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. G Medical Innovations Holdings's current EV-to-OCF is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current EV-to-OCF of 0.00. The current EV-to-OCF is 0.00. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current EV-to-OCF is 0.00 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score
Get the complete analysis for GMVDF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GMVDF has been successfully added to your 
